nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—ABCC3—hematologic cancer	0.14	0.592	CbGaD
Cyclosporine—ABCG2—hematologic cancer	0.0678	0.288	CbGaD
Cyclosporine—ABCB1—hematologic cancer	0.0282	0.12	CbGaD
Cyclosporine—ABCC10—Daunorubicin—hematologic cancer	0.0219	0.0495	CbGbCtD
Cyclosporine—ABCC10—Cytarabine—hematologic cancer	0.0193	0.0437	CbGbCtD
Cyclosporine—ABCC1—Idarubicin—hematologic cancer	0.0119	0.027	CbGbCtD
Cyclosporine—ABCB11—Daunorubicin—hematologic cancer	0.0119	0.0269	CbGbCtD
Cyclosporine—ABCC10—Gemcitabine—hematologic cancer	0.0117	0.0266	CbGbCtD
Cyclosporine—SLCO1A2—Chlorambucil—hematologic cancer	0.0107	0.0241	CbGbCtD
Cyclosporine—ABCG2—Clofarabine—hematologic cancer	0.00964	0.0218	CbGbCtD
Cyclosporine—ABCC10—Vincristine—hematologic cancer	0.00915	0.0207	CbGbCtD
Cyclosporine—ABCC1—Daunorubicin—hematologic cancer	0.00845	0.0191	CbGbCtD
Cyclosporine—ABCC10—Etoposide—hematologic cancer	0.00838	0.019	CbGbCtD
Cyclosporine—ABCC2—Daunorubicin—hematologic cancer	0.00625	0.0142	CbGbCtD
Cyclosporine—ABCC3—Vincristine—hematologic cancer	0.00575	0.013	CbGbCtD
Cyclosporine—ABCC10—Doxorubicin—hematologic cancer	0.00572	0.013	CbGbCtD
Cyclosporine—ABCG2—Daunorubicin—hematologic cancer	0.00565	0.0128	CbGbCtD
Cyclosporine—ABCC10—Methotrexate—hematologic cancer	0.00554	0.0125	CbGbCtD
Cyclosporine—ABCC3—Cisplatin—hematologic cancer	0.00537	0.0122	CbGbCtD
Cyclosporine—ABCC3—Etoposide—hematologic cancer	0.00527	0.0119	CbGbCtD
Cyclosporine—ABCC1—Mitoxantrone—hematologic cancer	0.00513	0.0116	CbGbCtD
Cyclosporine—ABCB11—Vinblastine—hematologic cancer	0.00506	0.0115	CbGbCtD
Cyclosporine—ABCB11—Vincristine—hematologic cancer	0.00497	0.0113	CbGbCtD
Cyclosporine—ABCG2—Teniposide—hematologic cancer	0.00491	0.0111	CbGbCtD
Cyclosporine—ABCG2—Cladribine—hematologic cancer	0.00471	0.0107	CbGbCtD
Cyclosporine—ABCG2—Imatinib—hematologic cancer	0.00433	0.00981	CbGbCtD
Cyclosporine—ABCC1—Epirubicin—hematologic cancer	0.00415	0.00941	CbGbCtD
Cyclosporine—ABCC1—Irinotecan—hematologic cancer	0.00404	0.00915	CbGbCtD
Cyclosporine—SLCO1A2—Prednisolone—hematologic cancer	0.00403	0.00913	CbGbCtD
Cyclosporine—ABCG2—Nilotinib—hematologic cancer	0.00393	0.00891	CbGbCtD
Cyclosporine—SLCO1A2—Prednisone—hematologic cancer	0.00381	0.00862	CbGbCtD
Cyclosporine—ABCB11—Dexamethasone—hematologic cancer	0.00375	0.00848	CbGbCtD
Cyclosporine—ABCC3—Doxorubicin—hematologic cancer	0.0036	0.00814	CbGbCtD
Cyclosporine—ABCC1—Vinblastine—hematologic cancer	0.00359	0.00814	CbGbCtD
Cyclosporine—CYP2C9—Bexarotene—hematologic cancer	0.00358	0.00811	CbGbCtD
Cyclosporine—ABCC1—Vincristine—hematologic cancer	0.00353	0.008	CbGbCtD
Cyclosporine—ABCC3—Methotrexate—hematologic cancer	0.00348	0.00789	CbGbCtD
Cyclosporine—ABCG2—Dasatinib—hematologic cancer	0.00348	0.00788	CbGbCtD
Cyclosporine—ABCB1—Lenalidomide—hematologic cancer	0.00348	0.00787	CbGbCtD
Cyclosporine—ABCG2—Mitoxantrone—hematologic cancer	0.00344	0.00778	CbGbCtD
Cyclosporine—SLCO1B1—Irinotecan—hematologic cancer	0.0034	0.00771	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00335	0.00758	CbGbCtD
Cyclosporine—CYP3A7—Ifosfamide—hematologic cancer	0.00335	0.00758	CbGbCtD
Cyclosporine—ABCC1—Etoposide—hematologic cancer	0.00324	0.00733	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0032	0.00724	CbGbCtD
Cyclosporine—CYP3A7—Imatinib—hematologic cancer	0.0032	0.00724	CbGbCtD
Cyclosporine—CYP2C8—Bortezomib—hematologic cancer	0.00315	0.00713	CbGbCtD
Cyclosporine—CYP3A5—Daunorubicin—hematologic cancer	0.00313	0.00709	CbGbCtD
Cyclosporine—ABCB11—Doxorubicin—hematologic cancer	0.00311	0.00704	CbGbCtD
Cyclosporine—CYP2D6—Lomustine—hematologic cancer	0.00305	0.0069	CbGbCtD
Cyclosporine—ABCC2—Irinotecan—hematologic cancer	0.00299	0.00677	CbGbCtD
Cyclosporine—CYP2C9—Idarubicin—hematologic cancer	0.00297	0.00672	CbGbCtD
Cyclosporine—CYP3A5—Thalidomide—hematologic cancer	0.00285	0.00646	CbGbCtD
Cyclosporine—CYP3A5—Teniposide—hematologic cancer	0.00272	0.00616	CbGbCtD
Cyclosporine—CYP2D6—Idarubicin—hematologic cancer	0.00271	0.00615	CbGbCtD
Cyclosporine—ABCG2—Irinotecan—hematologic cancer	0.0027	0.00612	CbGbCtD
Cyclosporine—ABCC2—Vinblastine—hematologic cancer	0.00266	0.00602	CbGbCtD
Cyclosporine—CYP2C19—Bortezomib—hematologic cancer	0.00264	0.00598	CbGbCtD
Cyclosporine—ABCC2—Vincristine—hematologic cancer	0.00261	0.00592	CbGbCtD
Cyclosporine—PPP3R2—gonad—hematologic cancer	0.00259	0.0481	CbGeAlD
Cyclosporine—CYP3A5—Ifosfamide—hematologic cancer	0.00251	0.00569	CbGbCtD
Cyclosporine—ABCC2—Cisplatin—hematologic cancer	0.00244	0.00552	CbGbCtD
Cyclosporine—CYP2C8—Ifosfamide—hematologic cancer	0.00241	0.00547	CbGbCtD
Cyclosporine—CYP3A5—Imatinib—hematologic cancer	0.0024	0.00543	CbGbCtD
Cyclosporine—ABCC2—Etoposide—hematologic cancer	0.0024	0.00543	CbGbCtD
Cyclosporine—SLCO1A2—Dexamethasone—hematologic cancer	0.00238	0.00538	CbGbCtD
Cyclosporine—ABCG2—Vincristine—hematologic cancer	0.00236	0.00535	CbGbCtD
Cyclosporine—CYP2D6—Hydroxyurea—hematologic cancer	0.00231	0.00523	CbGbCtD
Cyclosporine—CYP2C19—Thalidomide—hematologic cancer	0.0023	0.00521	CbGbCtD
Cyclosporine—ABCC1—Doxorubicin—hematologic cancer	0.00221	0.005	CbGbCtD
Cyclosporine—ABCG2—Cisplatin—hematologic cancer	0.0022	0.00499	CbGbCtD
Cyclosporine—CYP2C9—Bortezomib—hematologic cancer	0.0022	0.00497	CbGbCtD
Cyclosporine—CYP2C19—Teniposide—hematologic cancer	0.00219	0.00497	CbGbCtD
Cyclosporine—ABCG2—Etoposide—hematologic cancer	0.00217	0.00491	CbGbCtD
Cyclosporine—ABCC1—Methotrexate—hematologic cancer	0.00214	0.00484	CbGbCtD
Cyclosporine—CYP2C8—Nilotinib—hematologic cancer	0.0021	0.00475	CbGbCtD
Cyclosporine—CYP3A4—Bexarotene—hematologic cancer	0.00208	0.00472	CbGbCtD
Cyclosporine—ABCB1—Daunorubicin—hematologic cancer	0.00204	0.00462	CbGbCtD
Cyclosporine—CYP2C19—Ifosfamide—hematologic cancer	0.00203	0.00459	CbGbCtD
Cyclosporine—CYP2D6—Bortezomib—hematologic cancer	0.00201	0.00455	CbGbCtD
Cyclosporine—CYP3A7—Irinotecan—hematologic cancer	0.002	0.00452	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.002	0.00452	CbGbCtD
Cyclosporine—ABCB1—Alitretinoin—hematologic cancer	0.002	0.00452	CbGbCtD
Cyclosporine—ABCC2—Dexamethasone—hematologic cancer	0.00197	0.00446	CbGbCtD
Cyclosporine—CYP3A4—Lomustine—hematologic cancer	0.00194	0.00439	CbGbCtD
Cyclosporine—CYP3A4—Busulfan—hematologic cancer	0.00194	0.00439	CbGbCtD
Cyclosporine—CYP2C19—Imatinib—hematologic cancer	0.00194	0.00438	CbGbCtD
Cyclosporine—CYP3A5—Dasatinib—hematologic cancer	0.00193	0.00436	CbGbCtD
Cyclosporine—CYP2C9—Thalidomide—hematologic cancer	0.00191	0.00433	CbGbCtD
Cyclosporine—SLCO1A2—Methotrexate—hematologic cancer	0.00191	0.00432	CbGbCtD
Cyclosporine—PPP3R2—testis—hematologic cancer	0.00187	0.0347	CbGeAlD
Cyclosporine—CYP2C9—Teniposide—hematologic cancer	0.00182	0.00413	CbGbCtD
Cyclosporine—SLCO1B1—Methotrexate—hematologic cancer	0.0018	0.00408	CbGbCtD
Cyclosporine—ABCG2—Dexamethasone—hematologic cancer	0.00178	0.00403	CbGbCtD
Cyclosporine—CYP3A7—Vincristine—hematologic cancer	0.00175	0.00395	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00175	0.00395	CbGbCtD
Cyclosporine—CYP3A4—Thiotepa—hematologic cancer	0.00173	0.00391	CbGbCtD
Cyclosporine—CYP2C9—Ifosfamide—hematologic cancer	0.00168	0.00381	CbGbCtD
Cyclosporine—ABCC2—Doxorubicin—hematologic cancer	0.00163	0.0037	CbGbCtD
Cyclosporine—CYP2C9—Imatinib—hematologic cancer	0.00161	0.00364	CbGbCtD
Cyclosporine—ABCC2—Methotrexate—hematologic cancer	0.00158	0.00359	CbGbCtD
Cyclosporine—ABCB1—Imatinib—hematologic cancer	0.00156	0.00354	CbGbCtD
Cyclosporine—CYP3A5—Irinotecan—hematologic cancer	0.0015	0.00339	CbGbCtD
Cyclosporine—ABCG2—Doxorubicin—hematologic cancer	0.00148	0.00335	CbGbCtD
Cyclosporine—CYP2D6—Imatinib—hematologic cancer	0.00147	0.00333	CbGbCtD
Cyclosporine—CYP2C9—Nilotinib—hematologic cancer	0.00146	0.00331	CbGbCtD
Cyclosporine—ABCG2—Methotrexate—hematologic cancer	0.00143	0.00324	CbGbCtD
Cyclosporine—ABCB1—Nilotinib—hematologic cancer	0.00142	0.00321	CbGbCtD
Cyclosporine—ABCB1—Vinorelbine—hematologic cancer	0.00141	0.00319	CbGbCtD
Cyclosporine—CYP3A4—Methoxsalen—hematologic cancer	0.00134	0.00304	CbGbCtD
Cyclosporine—CYP2D6—Nilotinib—hematologic cancer	0.00134	0.00303	CbGbCtD
Cyclosporine—CYP2D6—Vinorelbine—hematologic cancer	0.00133	0.003	CbGbCtD
Cyclosporine—CYP3A7—Dexamethasone—hematologic cancer	0.00132	0.00298	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00132	0.00298	CbGbCtD
Cyclosporine—CYP3A5—Vincristine—hematologic cancer	0.00131	0.00297	CbGbCtD
Cyclosporine—SLC10A2—hematopoietic system—hematologic cancer	0.0013	0.0243	CbGeAlD
Cyclosporine—FKBP4—hematopoietic system—hematologic cancer	0.00129	0.024	CbGeAlD
Cyclosporine—CYP3A4—Bortezomib—hematologic cancer	0.00128	0.00289	CbGbCtD
Cyclosporine—CYP2C19—Prednisone—hematologic cancer	0.00127	0.00289	CbGbCtD
Cyclosporine—ABCB1—Dasatinib—hematologic cancer	0.00125	0.00284	CbGbCtD
Cyclosporine—ABCB1—Mitoxantrone—hematologic cancer	0.00124	0.00281	CbGbCtD
Cyclosporine—CYP3A4—Daunorubicin—hematologic cancer	0.00122	0.00277	CbGbCtD
Cyclosporine—PPIF—Ponatinib—Nilotinib—hematologic cancer	0.0012	0.569	CbGdCrCtD
Cyclosporine—CYP3A5—Etoposide—hematologic cancer	0.0012	0.00272	CbGbCtD
Cyclosporine—PPID—hematopoietic system—hematologic cancer	0.00119	0.0222	CbGeAlD
Cyclosporine—CAMLG—hematopoietic system—hematologic cancer	0.00118	0.0219	CbGeAlD
Cyclosporine—SLC22A6—Methotrexate—hematologic cancer	0.00116	0.00262	CbGbCtD
Cyclosporine—CYP2C8—Etoposide—hematologic cancer	0.00115	0.00261	CbGbCtD
Cyclosporine—FKBP1B—lung—hematologic cancer	0.00114	0.0211	CbGeAlD
Cyclosporine—ABCB1—Betamethasone—hematologic cancer	0.0011	0.0025	CbGbCtD
Cyclosporine—ABCB1—Gemcitabine—hematologic cancer	0.00109	0.00248	CbGbCtD
Cyclosporine—ABCB1—Prednisolone—hematologic cancer	0.00109	0.00247	CbGbCtD
Cyclosporine—CYP3A4—Cytarabine—hematologic cancer	0.00108	0.00244	CbGbCtD
Cyclosporine—FKBP1B—testis—hematologic cancer	0.00107	0.0199	CbGeAlD
Cyclosporine—CYP3A4—Teniposide—hematologic cancer	0.00106	0.0024	CbGbCtD
Cyclosporine—ABCB1—Prednisone—hematologic cancer	0.00103	0.00233	CbGbCtD
Cyclosporine—CYP3A5—Dexamethasone—hematologic cancer	0.000987	0.00223	CbGbCtD
Cyclosporine—FKBP4—gonad—hematologic cancer	0.000983	0.0183	CbGeAlD
Cyclosporine—CYP3A4—Ifosfamide—hematologic cancer	0.000979	0.00222	CbGbCtD
Cyclosporine—ABCB1—Irinotecan—hematologic cancer	0.000975	0.00221	CbGbCtD
Cyclosporine—CYP2C8—Dexamethasone—hematologic cancer	0.000949	0.00215	CbGbCtD
Cyclosporine—CYP3A4—Imatinib—hematologic cancer	0.000935	0.00212	CbGbCtD
Cyclosporine—PPIF—Ponatinib—Imatinib—hematologic cancer	0.00091	0.431	CbGdCrCtD
Cyclosporine—PPID—gonad—hematologic cancer	0.000907	0.0169	CbGeAlD
Cyclosporine—CAMLG—gonad—hematologic cancer	0.000894	0.0166	CbGeAlD
Cyclosporine—CYP3A4—Ruxolitinib—hematologic cancer	0.000881	0.00199	CbGbCtD
Cyclosporine—PPIF—hematopoietic system—hematologic cancer	0.000867	0.0161	CbGeAlD
Cyclosporine—ABCB1—Vinblastine—hematologic cancer	0.000867	0.00196	CbGbCtD
Cyclosporine—SLC10A2—blood—hematologic cancer	0.000864	0.0161	CbGeAlD
Cyclosporine—FKBP4—blood—hematologic cancer	0.000856	0.0159	CbGeAlD
Cyclosporine—ABCB1—Vincristine—hematologic cancer	0.000852	0.00193	CbGbCtD
Cyclosporine—CYP3A4—Nilotinib—hematologic cancer	0.00085	0.00193	CbGbCtD
Cyclosporine—CYP3A4—Vinorelbine—hematologic cancer	0.000843	0.00191	CbGbCtD
Cyclosporine—PPP3CA—hematopoietic system—hematologic cancer	0.000831	0.0155	CbGeAlD
Cyclosporine—PPIB—hematopoietic system—hematologic cancer	0.000826	0.0154	CbGeAlD
Cyclosporine—CYP2C9—Cisplatin—hematologic cancer	0.000819	0.00186	CbGbCtD
Cyclosporine—CYP2D6—Vinblastine—hematologic cancer	0.000817	0.00185	CbGbCtD
Cyclosporine—CYP2C19—Dexamethasone—hematologic cancer	0.000796	0.0018	CbGbCtD
Cyclosporine—ABCB1—Cisplatin—hematologic cancer	0.000795	0.0018	CbGbCtD
Cyclosporine—PPID—blood—hematologic cancer	0.00079	0.0147	CbGeAlD
Cyclosporine—ABCB1—Etoposide—hematologic cancer	0.000781	0.00177	CbGbCtD
Cyclosporine—CAMLG—blood—hematologic cancer	0.000779	0.0145	CbGeAlD
Cyclosporine—FKBP1B—lymph node—hematologic cancer	0.000777	0.0144	CbGeAlD
Cyclosporine—CYP3A4—Triamcinolone—hematologic cancer	0.000771	0.00175	CbGbCtD
Cyclosporine—PPID—bone marrow—hematologic cancer	0.000765	0.0142	CbGeAlD
Cyclosporine—CAMLG—bone marrow—hematologic cancer	0.000754	0.014	CbGeAlD
Cyclosporine—CYP3A4—Dasatinib—hematologic cancer	0.000751	0.0017	CbGbCtD
Cyclosporine—FKBP4—lung—hematologic cancer	0.000751	0.014	CbGeAlD
Cyclosporine—CYP3A4—Mitoxantrone—hematologic cancer	0.000742	0.00168	CbGbCtD
Cyclosporine—PPIA—blood—hematologic cancer	0.00071	0.0132	CbGeAlD
Cyclosporine—FKBP4—testis—hematologic cancer	0.000708	0.0132	CbGeAlD
Cyclosporine—PPID—lung—hematologic cancer	0.000693	0.0129	CbGeAlD
Cyclosporine—PPIA—bone marrow—hematologic cancer	0.000687	0.0128	CbGeAlD
Cyclosporine—CAMLG—lung—hematologic cancer	0.000683	0.0127	CbGeAlD
Cyclosporine—CYP2C9—Dexamethasone—hematologic cancer	0.000662	0.0015	CbGbCtD
Cyclosporine—CYP3A4—Betamethasone—hematologic cancer	0.000661	0.0015	CbGbCtD
Cyclosporine—PPIF—gonad—hematologic cancer	0.00066	0.0123	CbGeAlD
Cyclosporine—PPID—testis—hematologic cancer	0.000654	0.0122	CbGeAlD
Cyclosporine—CYP3A4—Prednisolone—hematologic cancer	0.000653	0.00148	CbGbCtD
Cyclosporine—CAMLG—testis—hematologic cancer	0.000644	0.012	CbGeAlD
Cyclosporine—ABCB1—Dexamethasone—hematologic cancer	0.000642	0.00145	CbGbCtD
Cyclosporine—PPIB—gonad—hematologic cancer	0.000628	0.0117	CbGeAlD
Cyclosporine—PPIA—lung—hematologic cancer	0.000622	0.0116	CbGeAlD
Cyclosporine—CYP3A4—Prednisone—hematologic cancer	0.000616	0.0014	CbGbCtD
Cyclosporine—CYP2D6—Dexamethasone—hematologic cancer	0.000605	0.00137	CbGbCtD
Cyclosporine—PPIA—testis—hematologic cancer	0.000587	0.0109	CbGeAlD
Cyclosporine—CYP3A4—Irinotecan—hematologic cancer	0.000584	0.00132	CbGbCtD
Cyclosporine—PPIF—blood—hematologic cancer	0.000575	0.0107	CbGeAlD
Cyclosporine—PPIF—bone marrow—hematologic cancer	0.000556	0.0103	CbGeAlD
Cyclosporine—FKBP1A—hematopoietic system—hematologic cancer	0.000552	0.0103	CbGeAlD
Cyclosporine—PPP3CA—blood—hematologic cancer	0.00055	0.0102	CbGeAlD
Cyclosporine—PPIB—blood—hematologic cancer	0.000547	0.0102	CbGeAlD
Cyclosporine—SLC10A1—gonad—hematologic cancer	0.000537	0.00999	CbGeAlD
Cyclosporine—ABCB1—Doxorubicin—hematologic cancer	0.000533	0.00121	CbGbCtD
Cyclosporine—PPP3CA—bone marrow—hematologic cancer	0.000532	0.0099	CbGeAlD
Cyclosporine—PPIB—bone marrow—hematologic cancer	0.000529	0.00985	CbGeAlD
Cyclosporine—CYP3A4—Vinblastine—hematologic cancer	0.000519	0.00118	CbGbCtD
Cyclosporine—ABCB1—Methotrexate—hematologic cancer	0.000516	0.00117	CbGbCtD
Cyclosporine—FKBP4—lymph node—hematologic cancer	0.000513	0.00955	CbGeAlD
Cyclosporine—CYP3A4—Vincristine—hematologic cancer	0.000511	0.00116	CbGbCtD
Cyclosporine—PPIF—lung—hematologic cancer	0.000504	0.00937	CbGeAlD
Cyclosporine—CYP2D6—Doxorubicin—hematologic cancer	0.000502	0.00114	CbGbCtD
Cyclosporine—PPP3CA—lung—hematologic cancer	0.000482	0.00897	CbGeAlD
Cyclosporine—PPIB—lung—hematologic cancer	0.00048	0.00892	CbGeAlD
Cyclosporine—PPIF—testis—hematologic cancer	0.000475	0.00884	CbGeAlD
Cyclosporine—PPID—lymph node—hematologic cancer	0.000474	0.00882	CbGeAlD
Cyclosporine—SLCO1B1—hematopoietic system—hematologic cancer	0.000468	0.00871	CbGeAlD
Cyclosporine—CYP3A4—Etoposide—hematologic cancer	0.000468	0.00106	CbGbCtD
Cyclosporine—CAMLG—lymph node—hematologic cancer	0.000467	0.00869	CbGeAlD
Cyclosporine—PPP3CA—testis—hematologic cancer	0.000455	0.00847	CbGeAlD
Cyclosporine—PPIB—testis—hematologic cancer	0.000452	0.00842	CbGeAlD
Cyclosporine—ABCC3—hematopoietic system—hematologic cancer	0.000444	0.00826	CbGeAlD
Cyclosporine—ABCC10—hematopoietic system—hematologic cancer	0.000442	0.00822	CbGeAlD
Cyclosporine—PPIA—lymph node—hematologic cancer	0.000425	0.00792	CbGeAlD
Cyclosporine—FKBP1A—gonad—hematologic cancer	0.00042	0.0078	CbGeAlD
Cyclosporine—SLC10A1—testis—hematologic cancer	0.000387	0.0072	CbGeAlD
Cyclosporine—CYP3A4—Dexamethasone—hematologic cancer	0.000385	0.000871	CbGbCtD
Cyclosporine—ABCB11—testis—hematologic cancer	0.000383	0.00712	CbGeAlD
Cyclosporine—SLCO1A2—hematopoietic system—hematologic cancer	0.000381	0.00709	CbGeAlD
Cyclosporine—FKBP1A—blood—hematologic cancer	0.000366	0.0068	CbGeAlD
Cyclosporine—FKBP1A—bone marrow—hematologic cancer	0.000354	0.00658	CbGeAlD
Cyclosporine—PPIF—lymph node—hematologic cancer	0.000345	0.00641	CbGeAlD
Cyclosporine—ABCC10—gonad—hematologic cancer	0.000336	0.00625	CbGeAlD
Cyclosporine—PPP3CA—lymph node—hematologic cancer	0.00033	0.00614	CbGeAlD
Cyclosporine—PPIB—lymph node—hematologic cancer	0.000328	0.0061	CbGeAlD
Cyclosporine—FKBP1A—lung—hematologic cancer	0.00032	0.00596	CbGeAlD
Cyclosporine—CYP3A4—Doxorubicin—hematologic cancer	0.000319	0.000723	CbGbCtD
Cyclosporine—SLCO1B1—blood—hematologic cancer	0.00031	0.00577	CbGeAlD
Cyclosporine—CYP2C19—hematopoietic system—hematologic cancer	0.000305	0.00567	CbGeAlD
Cyclosporine—FKBP1A—testis—hematologic cancer	0.000302	0.00563	CbGeAlD
Cyclosporine—ABCC3—blood—hematologic cancer	0.000294	0.00548	CbGeAlD
Cyclosporine—ABCC10—blood—hematologic cancer	0.000293	0.00545	CbGeAlD
Cyclosporine—ABCC10—bone marrow—hematologic cancer	0.000283	0.00527	CbGeAlD
Cyclosporine—CYP2C8—hematopoietic system—hematologic cancer	0.000266	0.00495	CbGeAlD
Cyclosporine—ABCC3—lung—hematologic cancer	0.000258	0.0048	CbGeAlD
Cyclosporine—ABCC10—lung—hematologic cancer	0.000257	0.00478	CbGeAlD
Cyclosporine—ABCC3—testis—hematologic cancer	0.000243	0.00453	CbGeAlD
Cyclosporine—ABCC10—testis—hematologic cancer	0.000242	0.00451	CbGeAlD
Cyclosporine—CYP3A5—hematopoietic system—hematologic cancer	0.00024	0.00447	CbGeAlD
Cyclosporine—CYP2C9—hematopoietic system—hematologic cancer	0.000236	0.0044	CbGeAlD
Cyclosporine—ABCC2—blood—hematologic cancer	0.000235	0.00437	CbGeAlD
Cyclosporine—SLCO1A2—lung—hematologic cancer	0.000221	0.00412	CbGeAlD
Cyclosporine—FKBP1A—lymph node—hematologic cancer	0.000219	0.00408	CbGeAlD
Cyclosporine—SLCO1A2—testis—hematologic cancer	0.000209	0.00388	CbGeAlD
Cyclosporine—ABCC1—blood—hematologic cancer	0.000207	0.00385	CbGeAlD
Cyclosporine—CYP2C19—blood—hematologic cancer	0.000202	0.00376	CbGeAlD
Cyclosporine—ABCC2—testis—hematologic cancer	0.000195	0.00362	CbGeAlD
Cyclosporine—ABCC1—lung—hematologic cancer	0.000182	0.00338	CbGeAlD
Cyclosporine—CYP3A4—hematopoietic system—hematologic cancer	0.00018	0.00335	CbGeAlD
Cyclosporine—CYP2D6—hematopoietic system—hematologic cancer	0.000177	0.0033	CbGeAlD
Cyclosporine—ABCC3—lymph node—hematologic cancer	0.000176	0.00328	CbGeAlD
Cyclosporine—CYP2C8—blood—hematologic cancer	0.000176	0.00328	CbGeAlD
Cyclosporine—ABCC10—lymph node—hematologic cancer	0.000176	0.00327	CbGeAlD
Cyclosporine—ABCG2—blood—hematologic cancer	0.000171	0.00319	CbGeAlD
Cyclosporine—ABCC1—testis—hematologic cancer	0.000171	0.00319	CbGeAlD
Cyclosporine—ABCG2—bone marrow—hematologic cancer	0.000166	0.00309	CbGeAlD
Cyclosporine—CYP3A5—blood—hematologic cancer	0.000159	0.00296	CbGeAlD
Cyclosporine—CYP2C9—blood—hematologic cancer	0.000157	0.00291	CbGeAlD
Cyclosporine—ABCG2—lung—hematologic cancer	0.00015	0.0028	CbGeAlD
Cyclosporine—CYP2C8—testis—hematologic cancer	0.000146	0.00271	CbGeAlD
Cyclosporine—ABCG2—testis—hematologic cancer	0.000142	0.00264	CbGeAlD
Cyclosporine—ABCC2—lymph node—hematologic cancer	0.000141	0.00262	CbGeAlD
Cyclosporine—CYP3A5—lung—hematologic cancer	0.00014	0.0026	CbGeAlD
Cyclosporine—ABCB1—hematopoietic system—hematologic cancer	0.000128	0.00237	CbGeAlD
Cyclosporine—ABCC1—lymph node—hematologic cancer	0.000124	0.00231	CbGeAlD
Cyclosporine—CYP3A4—blood—hematologic cancer	0.000119	0.00222	CbGeAlD
Cyclosporine—CYP2D6—blood—hematologic cancer	0.000118	0.00219	CbGeAlD
Cyclosporine—ABCG2—lymph node—hematologic cancer	0.000103	0.00191	CbGeAlD
Cyclosporine—CYP2D6—testis—hematologic cancer	9.72e-05	0.00181	CbGeAlD
Cyclosporine—ABCB1—gonad—hematologic cancer	9.7e-05	0.00181	CbGeAlD
Cyclosporine—ABCB1—blood—hematologic cancer	8.46e-05	0.00157	CbGeAlD
Cyclosporine—ABCB1—bone marrow—hematologic cancer	8.18e-05	0.00152	CbGeAlD
Cyclosporine—ABCB1—lung—hematologic cancer	7.41e-05	0.00138	CbGeAlD
Cyclosporine—ABCB1—testis—hematologic cancer	6.99e-05	0.0013	CbGeAlD
Cyclosporine—ABCB1—lymph node—hematologic cancer	5.07e-05	0.000943	CbGeAlD
Cyclosporine—Skin disorder—Prednisone—hematologic cancer	7.55e-06	4.57e-05	CcSEcCtD
Cyclosporine—Nausea—Gemcitabine—hematologic cancer	7.54e-06	4.57e-05	CcSEcCtD
Cyclosporine—Vomiting—Cisplatin—hematologic cancer	7.53e-06	4.56e-05	CcSEcCtD
Cyclosporine—Hyperhidrosis—Prednisone—hematologic cancer	7.51e-06	4.55e-05	CcSEcCtD
Cyclosporine—Vision blurred—Methotrexate—hematologic cancer	7.5e-06	4.55e-05	CcSEcCtD
Cyclosporine—Mental disorder—Epirubicin—hematologic cancer	7.5e-06	4.54e-05	CcSEcCtD
Cyclosporine—Rash—Cisplatin—hematologic cancer	7.46e-06	4.52e-05	CcSEcCtD
Cyclosporine—Dermatitis—Cisplatin—hematologic cancer	7.46e-06	4.52e-05	CcSEcCtD
Cyclosporine—Malnutrition—Epirubicin—hematologic cancer	7.45e-06	4.51e-05	CcSEcCtD
Cyclosporine—Diarrhoea—Etoposide—hematologic cancer	7.42e-06	4.5e-05	CcSEcCtD
Cyclosporine—Anorexia—Prednisone—hematologic cancer	7.41e-06	4.49e-05	CcSEcCtD
Cyclosporine—Ill-defined disorder—Methotrexate—hematologic cancer	7.38e-06	4.48e-05	CcSEcCtD
Cyclosporine—Tinnitus—Doxorubicin—hematologic cancer	7.38e-06	4.47e-05	CcSEcCtD
Cyclosporine—Anaemia—Methotrexate—hematologic cancer	7.36e-06	4.46e-05	CcSEcCtD
Cyclosporine—Feeling abnormal—Betamethasone—hematologic cancer	7.35e-06	4.46e-05	CcSEcCtD
Cyclosporine—Feeling abnormal—Dexamethasone—hematologic cancer	7.35e-06	4.46e-05	CcSEcCtD
Cyclosporine—Flushing—Doxorubicin—hematologic cancer	7.35e-06	4.45e-05	CcSEcCtD
Cyclosporine—Flatulence—Epirubicin—hematologic cancer	7.34e-06	4.45e-05	CcSEcCtD
Cyclosporine—Tension—Epirubicin—hematologic cancer	7.31e-06	4.43e-05	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.3e-06	4.42e-05	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Betamethasone—hematologic cancer	7.3e-06	4.42e-05	CcSEcCtD
Cyclosporine—Dysgeusia—Epirubicin—hematologic cancer	7.29e-06	4.42e-05	CcSEcCtD
Cyclosporine—Hypersensitivity—Triamcinolone—hematologic cancer	7.25e-06	4.39e-05	CcSEcCtD
Cyclosporine—Nervousness—Epirubicin—hematologic cancer	7.23e-06	4.38e-05	CcSEcCtD
Cyclosporine—Angiopathy—Doxorubicin—hematologic cancer	7.18e-06	4.35e-05	CcSEcCtD
Cyclosporine—Malaise—Methotrexate—hematologic cancer	7.18e-06	4.35e-05	CcSEcCtD
Cyclosporine—Dizziness—Etoposide—hematologic cancer	7.17e-06	4.35e-05	CcSEcCtD
Cyclosporine—Muscle spasms—Epirubicin—hematologic cancer	7.16e-06	4.34e-05	CcSEcCtD
Cyclosporine—Vertigo—Methotrexate—hematologic cancer	7.15e-06	4.33e-05	CcSEcCtD
Cyclosporine—Mediastinal disorder—Doxorubicin—hematologic cancer	7.13e-06	4.32e-05	CcSEcCtD
Cyclosporine—Leukopenia—Methotrexate—hematologic cancer	7.12e-06	4.32e-05	CcSEcCtD
Cyclosporine—Chills—Doxorubicin—hematologic cancer	7.1e-06	4.3e-05	CcSEcCtD
Cyclosporine—Urticaria—Dexamethasone—hematologic cancer	7.09e-06	4.3e-05	CcSEcCtD
Cyclosporine—Urticaria—Betamethasone—hematologic cancer	7.09e-06	4.3e-05	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Prednisone—hematologic cancer	7.08e-06	4.29e-05	CcSEcCtD
Cyclosporine—Dizziness—Prednisolone—hematologic cancer	7.07e-06	4.29e-05	CcSEcCtD
Cyclosporine—Arrhythmia—Doxorubicin—hematologic cancer	7.07e-06	4.29e-05	CcSEcCtD
Cyclosporine—Asthenia—Triamcinolone—hematologic cancer	7.06e-06	4.28e-05	CcSEcCtD
Cyclosporine—Body temperature increased—Dexamethasone—hematologic cancer	7.05e-06	4.28e-05	CcSEcCtD
Cyclosporine—Body temperature increased—Betamethasone—hematologic cancer	7.05e-06	4.28e-05	CcSEcCtD
Cyclosporine—Abdominal pain—Dexamethasone—hematologic cancer	7.05e-06	4.28e-05	CcSEcCtD
Cyclosporine—Abdominal pain—Betamethasone—hematologic cancer	7.05e-06	4.28e-05	CcSEcCtD
Cyclosporine—Nausea—Cisplatin—hematologic cancer	7.03e-06	4.26e-05	CcSEcCtD
Cyclosporine—Insomnia—Prednisone—hematologic cancer	7.03e-06	4.26e-05	CcSEcCtD
Cyclosporine—Vision blurred—Epirubicin—hematologic cancer	7.02e-06	4.25e-05	CcSEcCtD
Cyclosporine—Alopecia—Doxorubicin—hematologic cancer	6.99e-06	4.24e-05	CcSEcCtD
Cyclosporine—Paraesthesia—Prednisone—hematologic cancer	6.98e-06	4.23e-05	CcSEcCtD
Cyclosporine—Pruritus—Triamcinolone—hematologic cancer	6.96e-06	4.22e-05	CcSEcCtD
Cyclosporine—Cough—Methotrexate—hematologic cancer	6.94e-06	4.21e-05	CcSEcCtD
Cyclosporine—Mental disorder—Doxorubicin—hematologic cancer	6.93e-06	4.2e-05	CcSEcCtD
Cyclosporine—Ill-defined disorder—Epirubicin—hematologic cancer	6.91e-06	4.19e-05	CcSEcCtD
Cyclosporine—Convulsion—Methotrexate—hematologic cancer	6.89e-06	4.18e-05	CcSEcCtD
Cyclosporine—Vomiting—Etoposide—hematologic cancer	6.89e-06	4.18e-05	CcSEcCtD
Cyclosporine—Malnutrition—Doxorubicin—hematologic cancer	6.89e-06	4.18e-05	CcSEcCtD
Cyclosporine—Anaemia—Epirubicin—hematologic cancer	6.88e-06	4.17e-05	CcSEcCtD
Cyclosporine—Agitation—Epirubicin—hematologic cancer	6.84e-06	4.15e-05	CcSEcCtD
Cyclosporine—Dyspepsia—Prednisone—hematologic cancer	6.84e-06	4.15e-05	CcSEcCtD
Cyclosporine—Rash—Etoposide—hematologic cancer	6.84e-06	4.14e-05	CcSEcCtD
Cyclosporine—Dermatitis—Etoposide—hematologic cancer	6.83e-06	4.14e-05	CcSEcCtD
Cyclosporine—Headache—Etoposide—hematologic cancer	6.79e-06	4.12e-05	CcSEcCtD
Cyclosporine—Flatulence—Doxorubicin—hematologic cancer	6.79e-06	4.12e-05	CcSEcCtD
Cyclosporine—Chest pain—Methotrexate—hematologic cancer	6.78e-06	4.11e-05	CcSEcCtD
Cyclosporine—Arthralgia—Methotrexate—hematologic cancer	6.78e-06	4.11e-05	CcSEcCtD
Cyclosporine—Myalgia—Methotrexate—hematologic cancer	6.78e-06	4.11e-05	CcSEcCtD
Cyclosporine—Tension—Doxorubicin—hematologic cancer	6.76e-06	4.1e-05	CcSEcCtD
Cyclosporine—Decreased appetite—Prednisone—hematologic cancer	6.76e-06	4.09e-05	CcSEcCtD
Cyclosporine—Dysgeusia—Doxorubicin—hematologic cancer	6.75e-06	4.09e-05	CcSEcCtD
Cyclosporine—Rash—Prednisolone—hematologic cancer	6.74e-06	4.09e-05	CcSEcCtD
Cyclosporine—Dermatitis—Prednisolone—hematologic cancer	6.74e-06	4.08e-05	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	6.73e-06	4.08e-05	CcSEcCtD
Cyclosporine—Malaise—Epirubicin—hematologic cancer	6.72e-06	4.07e-05	CcSEcCtD
Cyclosporine—Fatigue—Prednisone—hematologic cancer	6.7e-06	4.06e-05	CcSEcCtD
Cyclosporine—Headache—Prednisolone—hematologic cancer	6.7e-06	4.06e-05	CcSEcCtD
Cyclosporine—Discomfort—Methotrexate—hematologic cancer	6.69e-06	4.06e-05	CcSEcCtD
Cyclosporine—Nervousness—Doxorubicin—hematologic cancer	6.69e-06	4.06e-05	CcSEcCtD
Cyclosporine—Vertigo—Epirubicin—hematologic cancer	6.69e-06	4.06e-05	CcSEcCtD
Cyclosporine—Leukopenia—Epirubicin—hematologic cancer	6.67e-06	4.04e-05	CcSEcCtD
Cyclosporine—Constipation—Prednisone—hematologic cancer	6.65e-06	4.03e-05	CcSEcCtD
Cyclosporine—Muscle spasms—Doxorubicin—hematologic cancer	6.62e-06	4.02e-05	CcSEcCtD
Cyclosporine—Confusional state—Methotrexate—hematologic cancer	6.55e-06	3.97e-05	CcSEcCtD
Cyclosporine—Dizziness—Triamcinolone—hematologic cancer	6.5e-06	3.94e-05	CcSEcCtD
Cyclosporine—Cough—Epirubicin—hematologic cancer	6.5e-06	3.94e-05	CcSEcCtD
Cyclosporine—Anaphylactic shock—Methotrexate—hematologic cancer	6.49e-06	3.94e-05	CcSEcCtD
Cyclosporine—Vision blurred—Doxorubicin—hematologic cancer	6.49e-06	3.94e-05	CcSEcCtD
Cyclosporine—Convulsion—Epirubicin—hematologic cancer	6.45e-06	3.91e-05	CcSEcCtD
Cyclosporine—Infection—Methotrexate—hematologic cancer	6.45e-06	3.91e-05	CcSEcCtD
Cyclosporine—Nausea—Etoposide—hematologic cancer	6.44e-06	3.9e-05	CcSEcCtD
Cyclosporine—Hypertension—Epirubicin—hematologic cancer	6.43e-06	3.9e-05	CcSEcCtD
Cyclosporine—Feeling abnormal—Prednisone—hematologic cancer	6.4e-06	3.88e-05	CcSEcCtD
Cyclosporine—Asthenia—Dexamethasone—hematologic cancer	6.4e-06	3.88e-05	CcSEcCtD
Cyclosporine—Asthenia—Betamethasone—hematologic cancer	6.4e-06	3.88e-05	CcSEcCtD
Cyclosporine—Ill-defined disorder—Doxorubicin—hematologic cancer	6.39e-06	3.87e-05	CcSEcCtD
Cyclosporine—Nervous system disorder—Methotrexate—hematologic cancer	6.37e-06	3.86e-05	CcSEcCtD
Cyclosporine—Anaemia—Doxorubicin—hematologic cancer	6.37e-06	3.86e-05	CcSEcCtD
Cyclosporine—Thrombocytopenia—Methotrexate—hematologic cancer	6.36e-06	3.85e-05	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Prednisone—hematologic cancer	6.35e-06	3.85e-05	CcSEcCtD
Cyclosporine—Nausea—Prednisolone—hematologic cancer	6.35e-06	3.85e-05	CcSEcCtD
Cyclosporine—Myalgia—Epirubicin—hematologic cancer	6.34e-06	3.84e-05	CcSEcCtD
Cyclosporine—Chest pain—Epirubicin—hematologic cancer	6.34e-06	3.84e-05	CcSEcCtD
Cyclosporine—Arthralgia—Epirubicin—hematologic cancer	6.34e-06	3.84e-05	CcSEcCtD
Cyclosporine—Agitation—Doxorubicin—hematologic cancer	6.33e-06	3.84e-05	CcSEcCtD
Cyclosporine—Anxiety—Epirubicin—hematologic cancer	6.32e-06	3.83e-05	CcSEcCtD
Cyclosporine—Pruritus—Betamethasone—hematologic cancer	6.31e-06	3.83e-05	CcSEcCtD
Cyclosporine—Pruritus—Dexamethasone—hematologic cancer	6.31e-06	3.83e-05	CcSEcCtD
Cyclosporine—Skin disorder—Methotrexate—hematologic cancer	6.31e-06	3.82e-05	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	6.3e-06	3.82e-05	CcSEcCtD
Cyclosporine—Hyperhidrosis—Methotrexate—hematologic cancer	6.28e-06	3.81e-05	CcSEcCtD
Cyclosporine—Discomfort—Epirubicin—hematologic cancer	6.26e-06	3.8e-05	CcSEcCtD
Cyclosporine—Vomiting—Triamcinolone—hematologic cancer	6.25e-06	3.79e-05	CcSEcCtD
Cyclosporine—Malaise—Doxorubicin—hematologic cancer	6.21e-06	3.77e-05	CcSEcCtD
Cyclosporine—Rash—Triamcinolone—hematologic cancer	6.2e-06	3.76e-05	CcSEcCtD
Cyclosporine—Dry mouth—Epirubicin—hematologic cancer	6.2e-06	3.76e-05	CcSEcCtD
Cyclosporine—Dermatitis—Triamcinolone—hematologic cancer	6.2e-06	3.75e-05	CcSEcCtD
Cyclosporine—Vertigo—Doxorubicin—hematologic cancer	6.19e-06	3.75e-05	CcSEcCtD
Cyclosporine—Anorexia—Methotrexate—hematologic cancer	6.19e-06	3.75e-05	CcSEcCtD
Cyclosporine—Urticaria—Prednisone—hematologic cancer	6.17e-06	3.74e-05	CcSEcCtD
Cyclosporine—Leukopenia—Doxorubicin—hematologic cancer	6.17e-06	3.74e-05	CcSEcCtD
Cyclosporine—Headache—Triamcinolone—hematologic cancer	6.16e-06	3.73e-05	CcSEcCtD
Cyclosporine—Abdominal pain—Prednisone—hematologic cancer	6.14e-06	3.72e-05	CcSEcCtD
Cyclosporine—Body temperature increased—Prednisone—hematologic cancer	6.14e-06	3.72e-05	CcSEcCtD
Cyclosporine—Confusional state—Epirubicin—hematologic cancer	6.13e-06	3.71e-05	CcSEcCtD
Cyclosporine—Diarrhoea—Dexamethasone—hematologic cancer	6.11e-06	3.7e-05	CcSEcCtD
Cyclosporine—Diarrhoea—Betamethasone—hematologic cancer	6.11e-06	3.7e-05	CcSEcCtD
Cyclosporine—Anaphylactic shock—Epirubicin—hematologic cancer	6.08e-06	3.68e-05	CcSEcCtD
Cyclosporine—Oedema—Epirubicin—hematologic cancer	6.08e-06	3.68e-05	CcSEcCtD
Cyclosporine—Infection—Epirubicin—hematologic cancer	6.04e-06	3.66e-05	CcSEcCtD
Cyclosporine—Cough—Doxorubicin—hematologic cancer	6.01e-06	3.64e-05	CcSEcCtD
Cyclosporine—Convulsion—Doxorubicin—hematologic cancer	5.97e-06	3.62e-05	CcSEcCtD
Cyclosporine—Nervous system disorder—Epirubicin—hematologic cancer	5.96e-06	3.61e-05	CcSEcCtD
Cyclosporine—Thrombocytopenia—Epirubicin—hematologic cancer	5.95e-06	3.61e-05	CcSEcCtD
Cyclosporine—Hypertension—Doxorubicin—hematologic cancer	5.95e-06	3.61e-05	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	5.92e-06	3.59e-05	CcSEcCtD
Cyclosporine—Skin disorder—Epirubicin—hematologic cancer	5.9e-06	3.58e-05	CcSEcCtD
Cyclosporine—Dizziness—Betamethasone—hematologic cancer	5.9e-06	3.58e-05	CcSEcCtD
Cyclosporine—Dizziness—Dexamethasone—hematologic cancer	5.9e-06	3.58e-05	CcSEcCtD
Cyclosporine—Hyperhidrosis—Epirubicin—hematologic cancer	5.88e-06	3.56e-05	CcSEcCtD
Cyclosporine—Insomnia—Methotrexate—hematologic cancer	5.87e-06	3.56e-05	CcSEcCtD
Cyclosporine—Chest pain—Doxorubicin—hematologic cancer	5.87e-06	3.56e-05	CcSEcCtD
Cyclosporine—Myalgia—Doxorubicin—hematologic cancer	5.87e-06	3.56e-05	CcSEcCtD
Cyclosporine—Arthralgia—Doxorubicin—hematologic cancer	5.87e-06	3.56e-05	CcSEcCtD
Cyclosporine—Anxiety—Doxorubicin—hematologic cancer	5.85e-06	3.54e-05	CcSEcCtD
Cyclosporine—Nausea—Triamcinolone—hematologic cancer	5.84e-06	3.54e-05	CcSEcCtD
Cyclosporine—Paraesthesia—Methotrexate—hematologic cancer	5.83e-06	3.53e-05	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	5.83e-06	3.53e-05	CcSEcCtD
Cyclosporine—Discomfort—Doxorubicin—hematologic cancer	5.8e-06	3.51e-05	CcSEcCtD
Cyclosporine—Anorexia—Epirubicin—hematologic cancer	5.79e-06	3.51e-05	CcSEcCtD
Cyclosporine—Dyspnoea—Methotrexate—hematologic cancer	5.79e-06	3.51e-05	CcSEcCtD
Cyclosporine—Somnolence—Methotrexate—hematologic cancer	5.77e-06	3.5e-05	CcSEcCtD
Cyclosporine—Dry mouth—Doxorubicin—hematologic cancer	5.74e-06	3.48e-05	CcSEcCtD
Cyclosporine—Hypersensitivity—Prednisone—hematologic cancer	5.73e-06	3.47e-05	CcSEcCtD
Cyclosporine—Dyspepsia—Methotrexate—hematologic cancer	5.72e-06	3.46e-05	CcSEcCtD
Cyclosporine—Vomiting—Dexamethasone—hematologic cancer	5.67e-06	3.44e-05	CcSEcCtD
Cyclosporine—Vomiting—Betamethasone—hematologic cancer	5.67e-06	3.44e-05	CcSEcCtD
Cyclosporine—Confusional state—Doxorubicin—hematologic cancer	5.67e-06	3.44e-05	CcSEcCtD
Cyclosporine—Decreased appetite—Methotrexate—hematologic cancer	5.65e-06	3.42e-05	CcSEcCtD
Cyclosporine—Rash—Betamethasone—hematologic cancer	5.63e-06	3.41e-05	CcSEcCtD
Cyclosporine—Rash—Dexamethasone—hematologic cancer	5.63e-06	3.41e-05	CcSEcCtD
Cyclosporine—Anaphylactic shock—Doxorubicin—hematologic cancer	5.62e-06	3.41e-05	CcSEcCtD
Cyclosporine—Oedema—Doxorubicin—hematologic cancer	5.62e-06	3.41e-05	CcSEcCtD
Cyclosporine—Dermatitis—Dexamethasone—hematologic cancer	5.62e-06	3.41e-05	CcSEcCtD
Cyclosporine—Dermatitis—Betamethasone—hematologic cancer	5.62e-06	3.41e-05	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Methotrexate—hematologic cancer	5.61e-06	3.4e-05	CcSEcCtD
Cyclosporine—Fatigue—Methotrexate—hematologic cancer	5.6e-06	3.39e-05	CcSEcCtD
Cyclosporine—Headache—Dexamethasone—hematologic cancer	5.59e-06	3.39e-05	CcSEcCtD
Cyclosporine—Headache—Betamethasone—hematologic cancer	5.59e-06	3.39e-05	CcSEcCtD
Cyclosporine—Infection—Doxorubicin—hematologic cancer	5.59e-06	3.39e-05	CcSEcCtD
Cyclosporine—Asthenia—Prednisone—hematologic cancer	5.58e-06	3.38e-05	CcSEcCtD
Cyclosporine—Pain—Methotrexate—hematologic cancer	5.55e-06	3.37e-05	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.54e-06	3.36e-05	CcSEcCtD
Cyclosporine—Nervous system disorder—Doxorubicin—hematologic cancer	5.52e-06	3.34e-05	CcSEcCtD
Cyclosporine—Thrombocytopenia—Doxorubicin—hematologic cancer	5.51e-06	3.34e-05	CcSEcCtD
Cyclosporine—Pruritus—Prednisone—hematologic cancer	5.5e-06	3.33e-05	CcSEcCtD
Cyclosporine—Insomnia—Epirubicin—hematologic cancer	5.5e-06	3.33e-05	CcSEcCtD
Cyclosporine—Skin disorder—Doxorubicin—hematologic cancer	5.46e-06	3.31e-05	CcSEcCtD
Cyclosporine—Paraesthesia—Epirubicin—hematologic cancer	5.46e-06	3.31e-05	CcSEcCtD
Cyclosporine—Hyperhidrosis—Doxorubicin—hematologic cancer	5.44e-06	3.3e-05	CcSEcCtD
Cyclosporine—Dyspnoea—Epirubicin—hematologic cancer	5.42e-06	3.28e-05	CcSEcCtD
Cyclosporine—Somnolence—Epirubicin—hematologic cancer	5.4e-06	3.27e-05	CcSEcCtD
Cyclosporine—Anorexia—Doxorubicin—hematologic cancer	5.36e-06	3.25e-05	CcSEcCtD
Cyclosporine—Feeling abnormal—Methotrexate—hematologic cancer	5.35e-06	3.24e-05	CcSEcCtD
Cyclosporine—Dyspepsia—Epirubicin—hematologic cancer	5.35e-06	3.24e-05	CcSEcCtD
Cyclosporine—Diarrhoea—Prednisone—hematologic cancer	5.32e-06	3.22e-05	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Methotrexate—hematologic cancer	5.31e-06	3.22e-05	CcSEcCtD
Cyclosporine—Nausea—Betamethasone—hematologic cancer	5.3e-06	3.21e-05	CcSEcCtD
Cyclosporine—Nausea—Dexamethasone—hematologic cancer	5.3e-06	3.21e-05	CcSEcCtD
Cyclosporine—Decreased appetite—Epirubicin—hematologic cancer	5.28e-06	3.2e-05	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.25e-06	3.18e-05	CcSEcCtD
Cyclosporine—Fatigue—Epirubicin—hematologic cancer	5.24e-06	3.18e-05	CcSEcCtD
Cyclosporine—Pain—Epirubicin—hematologic cancer	5.2e-06	3.15e-05	CcSEcCtD
Cyclosporine—Constipation—Epirubicin—hematologic cancer	5.2e-06	3.15e-05	CcSEcCtD
Cyclosporine—Urticaria—Methotrexate—hematologic cancer	5.16e-06	3.13e-05	CcSEcCtD
Cyclosporine—Dizziness—Prednisone—hematologic cancer	5.14e-06	3.11e-05	CcSEcCtD
Cyclosporine—Abdominal pain—Methotrexate—hematologic cancer	5.13e-06	3.11e-05	CcSEcCtD
Cyclosporine—Body temperature increased—Methotrexate—hematologic cancer	5.13e-06	3.11e-05	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.12e-06	3.11e-05	CcSEcCtD
Cyclosporine—Insomnia—Doxorubicin—hematologic cancer	5.09e-06	3.08e-05	CcSEcCtD
Cyclosporine—Paraesthesia—Doxorubicin—hematologic cancer	5.05e-06	3.06e-05	CcSEcCtD
Cyclosporine—Dyspnoea—Doxorubicin—hematologic cancer	5.01e-06	3.04e-05	CcSEcCtD
Cyclosporine—Feeling abnormal—Epirubicin—hematologic cancer	5.01e-06	3.04e-05	CcSEcCtD
Cyclosporine—Somnolence—Doxorubicin—hematologic cancer	5e-06	3.03e-05	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Epirubicin—hematologic cancer	4.97e-06	3.01e-05	CcSEcCtD
Cyclosporine—Dyspepsia—Doxorubicin—hematologic cancer	4.95e-06	3e-05	CcSEcCtD
Cyclosporine—Vomiting—Prednisone—hematologic cancer	4.94e-06	2.99e-05	CcSEcCtD
Cyclosporine—Rash—Prednisone—hematologic cancer	4.9e-06	2.97e-05	CcSEcCtD
Cyclosporine—Dermatitis—Prednisone—hematologic cancer	4.9e-06	2.97e-05	CcSEcCtD
Cyclosporine—Decreased appetite—Doxorubicin—hematologic cancer	4.89e-06	2.96e-05	CcSEcCtD
Cyclosporine—Headache—Prednisone—hematologic cancer	4.87e-06	2.95e-05	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.86e-06	2.94e-05	CcSEcCtD
Cyclosporine—Fatigue—Doxorubicin—hematologic cancer	4.85e-06	2.94e-05	CcSEcCtD
Cyclosporine—Urticaria—Epirubicin—hematologic cancer	4.83e-06	2.93e-05	CcSEcCtD
Cyclosporine—Pain—Doxorubicin—hematologic cancer	4.81e-06	2.91e-05	CcSEcCtD
Cyclosporine—Constipation—Doxorubicin—hematologic cancer	4.81e-06	2.91e-05	CcSEcCtD
Cyclosporine—Abdominal pain—Epirubicin—hematologic cancer	4.8e-06	2.91e-05	CcSEcCtD
Cyclosporine—Body temperature increased—Epirubicin—hematologic cancer	4.8e-06	2.91e-05	CcSEcCtD
Cyclosporine—Hypersensitivity—Methotrexate—hematologic cancer	4.79e-06	2.9e-05	CcSEcCtD
Cyclosporine—Asthenia—Methotrexate—hematologic cancer	4.66e-06	2.82e-05	CcSEcCtD
Cyclosporine—Feeling abnormal—Doxorubicin—hematologic cancer	4.63e-06	2.81e-05	CcSEcCtD
Cyclosporine—Nausea—Prednisone—hematologic cancer	4.62e-06	2.8e-05	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.6e-06	2.79e-05	CcSEcCtD
Cyclosporine—Pruritus—Methotrexate—hematologic cancer	4.59e-06	2.78e-05	CcSEcCtD
Cyclosporine—Hypersensitivity—Epirubicin—hematologic cancer	4.48e-06	2.71e-05	CcSEcCtD
Cyclosporine—Urticaria—Doxorubicin—hematologic cancer	4.47e-06	2.71e-05	CcSEcCtD
Cyclosporine—Body temperature increased—Doxorubicin—hematologic cancer	4.45e-06	2.69e-05	CcSEcCtD
Cyclosporine—Abdominal pain—Doxorubicin—hematologic cancer	4.45e-06	2.69e-05	CcSEcCtD
Cyclosporine—Diarrhoea—Methotrexate—hematologic cancer	4.44e-06	2.69e-05	CcSEcCtD
Cyclosporine—Asthenia—Epirubicin—hematologic cancer	4.36e-06	2.64e-05	CcSEcCtD
Cyclosporine—Pruritus—Epirubicin—hematologic cancer	4.3e-06	2.61e-05	CcSEcCtD
Cyclosporine—Dizziness—Methotrexate—hematologic cancer	4.29e-06	2.6e-05	CcSEcCtD
Cyclosporine—Diarrhoea—Epirubicin—hematologic cancer	4.16e-06	2.52e-05	CcSEcCtD
Cyclosporine—Hypersensitivity—Doxorubicin—hematologic cancer	4.14e-06	2.51e-05	CcSEcCtD
Cyclosporine—Vomiting—Methotrexate—hematologic cancer	4.13e-06	2.5e-05	CcSEcCtD
Cyclosporine—Rash—Methotrexate—hematologic cancer	4.1e-06	2.48e-05	CcSEcCtD
Cyclosporine—Dermatitis—Methotrexate—hematologic cancer	4.09e-06	2.48e-05	CcSEcCtD
Cyclosporine—Headache—Methotrexate—hematologic cancer	4.07e-06	2.47e-05	CcSEcCtD
Cyclosporine—Asthenia—Doxorubicin—hematologic cancer	4.03e-06	2.45e-05	CcSEcCtD
Cyclosporine—Dizziness—Epirubicin—hematologic cancer	4.02e-06	2.44e-05	CcSEcCtD
Cyclosporine—Pruritus—Doxorubicin—hematologic cancer	3.98e-06	2.41e-05	CcSEcCtD
Cyclosporine—Vomiting—Epirubicin—hematologic cancer	3.86e-06	2.34e-05	CcSEcCtD
Cyclosporine—Nausea—Methotrexate—hematologic cancer	3.86e-06	2.34e-05	CcSEcCtD
Cyclosporine—Diarrhoea—Doxorubicin—hematologic cancer	3.85e-06	2.33e-05	CcSEcCtD
Cyclosporine—Rash—Epirubicin—hematologic cancer	3.83e-06	2.32e-05	CcSEcCtD
Cyclosporine—Dermatitis—Epirubicin—hematologic cancer	3.83e-06	2.32e-05	CcSEcCtD
Cyclosporine—Headache—Epirubicin—hematologic cancer	3.81e-06	2.31e-05	CcSEcCtD
Cyclosporine—Dizziness—Doxorubicin—hematologic cancer	3.72e-06	2.25e-05	CcSEcCtD
Cyclosporine—Nausea—Epirubicin—hematologic cancer	3.61e-06	2.19e-05	CcSEcCtD
Cyclosporine—Vomiting—Doxorubicin—hematologic cancer	3.58e-06	2.17e-05	CcSEcCtD
Cyclosporine—Rash—Doxorubicin—hematologic cancer	3.55e-06	2.15e-05	CcSEcCtD
Cyclosporine—Dermatitis—Doxorubicin—hematologic cancer	3.54e-06	2.15e-05	CcSEcCtD
Cyclosporine—Headache—Doxorubicin—hematologic cancer	3.52e-06	2.14e-05	CcSEcCtD
Cyclosporine—Nausea—Doxorubicin—hematologic cancer	3.34e-06	2.02e-05	CcSEcCtD
Cyclosporine—ABCC1—Metabolism—CREBBP—hematologic cancer	1.01e-06	9.93e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—SDC1—hematologic cancer	1.01e-06	9.92e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.01e-06	9.91e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GSTP1—hematologic cancer	1.01e-06	9.9e-06	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	1.01e-06	9.88e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—SDC1—hematologic cancer	1e-06	9.84e-06	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—HRAS—hematologic cancer	9.99e-07	9.81e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MTOR—hematologic cancer	9.99e-07	9.8e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CB—hematologic cancer	9.99e-07	9.8e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CD4—hematologic cancer	9.97e-07	9.78e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.92e-07	9.73e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYCS—hematologic cancer	9.91e-07	9.72e-06	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MYC—hematologic cancer	9.87e-07	9.68e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	9.85e-07	9.66e-06	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TGFB1—hematologic cancer	9.84e-07	9.66e-06	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—AKT1—hematologic cancer	9.77e-07	9.59e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ARNTL—hematologic cancer	9.64e-07	9.47e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	9.62e-07	9.44e-06	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTEN—hematologic cancer	9.62e-07	9.44e-06	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—CREBBP—hematologic cancer	9.62e-07	9.44e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CG—hematologic cancer	9.6e-07	9.42e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CD—hematologic cancer	9.59e-07	9.42e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	9.57e-07	9.4e-06	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL6—hematologic cancer	9.56e-07	9.39e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ABCB1—hematologic cancer	9.55e-07	9.37e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CG—hematologic cancer	9.52e-07	9.34e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—ALB—hematologic cancer	9.47e-07	9.29e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	9.45e-07	9.28e-06	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—AKT1—hematologic cancer	9.41e-07	9.23e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CA9—hematologic cancer	9.38e-07	9.21e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ACP5—hematologic cancer	9.38e-07	9.21e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CDKN1B—hematologic cancer	9.37e-07	9.2e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—NQO1—hematologic cancer	9.35e-07	9.17e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CD44—hematologic cancer	9.35e-07	9.17e-06	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	9.29e-07	9.12e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—NCOR1—hematologic cancer	9.27e-07	9.09e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GSTM1—hematologic cancer	9.27e-07	9.09e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NCOR2—hematologic cancer	9.26e-07	9.09e-06	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTEN—hematologic cancer	9.22e-07	9.05e-06	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—EP300—hematologic cancer	9.17e-07	9e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.15e-07	8.98e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—NQO1—hematologic cancer	9.12e-07	8.95e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CD44—hematologic cancer	9.12e-07	8.95e-06	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	9.12e-07	8.95e-06	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KRAS—hematologic cancer	9.12e-07	8.95e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3R1—hematologic cancer	9.06e-07	8.89e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.04e-07	8.87e-06	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ALB—hematologic cancer	9e-07	8.83e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—CREBBP—hematologic cancer	8.9e-07	8.74e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.86e-07	8.7e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYCS—hematologic cancer	8.84e-07	8.68e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—CREBBP—hematologic cancer	8.83e-07	8.66e-06	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—AKT1—hematologic cancer	8.82e-07	8.66e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—IDH1—hematologic cancer	8.82e-07	8.66e-06	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—EP300—hematologic cancer	8.79e-07	8.63e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	8.79e-07	8.62e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GSTP1—hematologic cancer	8.73e-07	8.57e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ABCC3—hematologic cancer	8.72e-07	8.56e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTO1—hematologic cancer	8.72e-07	8.56e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—TXN—hematologic cancer	8.72e-07	8.56e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CDKN1A—hematologic cancer	8.65e-07	8.49e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYCS—hematologic cancer	8.63e-07	8.47e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTEN—hematologic cancer	8.63e-07	8.47e-06	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	8.61e-07	8.45e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CD44—hematologic cancer	8.6e-07	8.44e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—NQO1—hematologic cancer	8.6e-07	8.44e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	8.58e-07	8.42e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SPHK1—hematologic cancer	8.54e-07	8.38e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CD44—hematologic cancer	8.52e-07	8.36e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—NQO1—hematologic cancer	8.52e-07	8.36e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.45e-07	8.29e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CD—hematologic cancer	8.44e-07	8.28e-06	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PIK3CA—hematologic cancer	8.38e-07	8.22e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CD—hematologic cancer	8.37e-07	8.21e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CB—hematologic cancer	8.36e-07	8.21e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.35e-07	8.19e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ALB—hematologic cancer	8.33e-07	8.18e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ABCB1—hematologic cancer	8.27e-07	8.11e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ALB—hematologic cancer	8.26e-07	8.11e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EP300—hematologic cancer	8.23e-07	8.08e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	8.2e-07	8.05e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—MTHFR—hematologic cancer	8.19e-07	8.04e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYCS—hematologic cancer	8.13e-07	7.98e-06	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—hematologic cancer	8.1e-07	7.95e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	8.08e-07	7.93e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYCS—hematologic cancer	8.06e-07	7.91e-06	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTEN—hematologic cancer	8.03e-07	7.88e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—NCOR1—hematologic cancer	8.03e-07	7.88e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GSTM1—hematologic cancer	8.03e-07	7.88e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	8.01e-07	7.86e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—SRC—hematologic cancer	8e-07	7.85e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CRABP1—hematologic cancer	7.98e-07	7.83e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	7.98e-07	7.83e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3R1—hematologic cancer	7.97e-07	7.82e-06	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	7.95e-07	7.8e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.91e-07	7.76e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3R1—hematologic cancer	7.9e-07	7.75e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTP1—hematologic cancer	7.8e-07	7.65e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ALOX5—hematologic cancer	7.77e-07	7.63e-06	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—HRAS—hematologic cancer	7.75e-07	7.6e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—STAT3—hematologic cancer	7.72e-07	7.57e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—NRAS—hematologic cancer	7.7e-07	7.55e-06	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—EP300—hematologic cancer	7.66e-07	7.52e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTP1—hematologic cancer	7.61e-07	7.47e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.54e-07	7.4e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NUP98—hematologic cancer	7.53e-07	7.39e-06	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL6—hematologic cancer	7.42e-07	7.28e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ABCB1—hematologic cancer	7.38e-07	7.24e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MAPK3—hematologic cancer	7.37e-07	7.24e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CB—hematologic cancer	7.36e-07	7.22e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NCOA3—hematologic cancer	7.31e-07	7.17e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ADCY7—hematologic cancer	7.31e-07	7.17e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CB—hematologic cancer	7.29e-07	7.16e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NUP214—hematologic cancer	7.26e-07	7.12e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTEN—hematologic cancer	7.23e-07	7.09e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.21e-07	7.08e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MYC—hematologic cancer	7.17e-07	7.04e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTP1—hematologic cancer	7.17e-07	7.04e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTM1—hematologic cancer	7.16e-07	7.03e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—NCOR1—hematologic cancer	7.16e-07	7.03e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—TGFB1—hematologic cancer	7.15e-07	7.02e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ABCG2—hematologic cancer	7.11e-07	6.98e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—MTR—hematologic cancer	7.11e-07	6.98e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTP1—hematologic cancer	7.11e-07	6.98e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—MTHFR—hematologic cancer	7.09e-07	6.96e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—NCOR1—hematologic cancer	6.99e-07	6.86e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTM1—hematologic cancer	6.99e-07	6.86e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ENO2—hematologic cancer	6.97e-07	6.84e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—EP300—hematologic cancer	6.89e-07	6.76e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	6.88e-07	6.75e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.88e-07	6.75e-06	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTEN—hematologic cancer	6.87e-07	6.74e-06	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—AKT1—hematologic cancer	6.84e-07	6.71e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ABCB1—hematologic cancer	6.79e-07	6.66e-06	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CA—hematologic cancer	6.79e-07	6.66e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.76e-07	6.64e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ABCB1—hematologic cancer	6.73e-07	6.6e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KRAS—hematologic cancer	6.63e-07	6.5e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SDC1—hematologic cancer	6.61e-07	6.49e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—NCOR1—hematologic cancer	6.59e-07	6.47e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTM1—hematologic cancer	6.59e-07	6.47e-06	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—EP300—hematologic cancer	6.55e-07	6.43e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTM1—hematologic cancer	6.53e-07	6.41e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—NCOR1—hematologic cancer	6.53e-07	6.41e-06	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CA—hematologic cancer	6.51e-07	6.38e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CREBBP—hematologic cancer	6.38e-07	6.26e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTEN—hematologic cancer	6.36e-07	6.24e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—MTHFR—hematologic cancer	6.33e-07	6.21e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTEN—hematologic cancer	6.3e-07	6.19e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.25e-07	6.13e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—MTHFR—hematologic cancer	6.18e-07	6.06e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CA—hematologic cancer	6.09e-07	5.97e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—EP300—hematologic cancer	6.06e-07	5.95e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	6.05e-07	5.94e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—EP300—hematologic cancer	6.01e-07	5.9e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ALB—hematologic cancer	5.97e-07	5.86e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	5.96e-07	5.85e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—MTHFR—hematologic cancer	5.82e-07	5.71e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—MTHFR—hematologic cancer	5.77e-07	5.67e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	5.71e-07	5.61e-06	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	5.67e-07	5.56e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HRAS—hematologic cancer	5.63e-07	5.53e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CD44—hematologic cancer	5.62e-07	5.52e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NQO1—hematologic cancer	5.62e-07	5.52e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.58e-07	5.48e-06	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—AKT1—hematologic cancer	5.54e-07	5.44e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CREBBP—hematologic cancer	5.53e-07	5.42e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—IL6—hematologic cancer	5.39e-07	5.29e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	5.32e-07	5.22e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYCS—hematologic cancer	5.32e-07	5.22e-06	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—AKT1—hematologic cancer	5.31e-07	5.22e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	5.28e-07	5.19e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	5.27e-07	5.17e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	5.24e-07	5.14e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CG—hematologic cancer	5.19e-07	5.1e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ALB—hematologic cancer	5.17e-07	5.08e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CA—hematologic cancer	5.1e-07	5e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.09e-07	4.99e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—AKT1—hematologic cancer	4.97e-07	4.88e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	4.95e-07	4.86e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CREBBP—hematologic cancer	4.93e-07	4.84e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	4.89e-07	4.8e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4.85e-07	4.76e-06	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	4.84e-07	4.75e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CREBBP—hematologic cancer	4.81e-07	4.72e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.69e-07	4.6e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	4.68e-07	4.59e-06	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—AKT1—hematologic cancer	4.63e-07	4.54e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ALB—hematologic cancer	4.62e-07	4.53e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	4.57e-07	4.48e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CD—hematologic cancer	4.56e-07	4.48e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTEN—hematologic cancer	4.56e-07	4.47e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CREBBP—hematologic cancer	4.54e-07	4.45e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ALB—hematologic cancer	4.51e-07	4.42e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CREBBP—hematologic cancer	4.5e-07	4.41e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CA—hematologic cancer	4.49e-07	4.4e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CA—hematologic cancer	4.45e-07	4.36e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ABCB1—hematologic cancer	4.44e-07	4.35e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	4.42e-07	4.33e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—EP300—hematologic cancer	4.34e-07	4.26e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3R1—hematologic cancer	4.31e-07	4.23e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NCOR1—hematologic cancer	4.31e-07	4.23e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTM1—hematologic cancer	4.31e-07	4.23e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	4.3e-07	4.22e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	4.26e-07	4.18e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ALB—hematologic cancer	4.25e-07	4.17e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ALB—hematologic cancer	4.21e-07	4.13e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—AKT1—hematologic cancer	4.16e-07	4.09e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	4.08e-07	4e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	4.06e-07	3.99e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	4.03e-07	3.95e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CB—hematologic cancer	3.98e-07	3.9e-06	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—AKT1—hematologic cancer	3.96e-07	3.88e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTEN—hematologic cancer	3.95e-07	3.87e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.81e-07	3.74e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—EP300—hematologic cancer	3.76e-07	3.69e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	3.75e-07	3.68e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.72e-07	3.65e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—AKT1—hematologic cancer	3.66e-07	3.6e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—AKT1—hematologic cancer	3.63e-07	3.56e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTEN—hematologic cancer	3.52e-07	3.46e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTEN—hematologic cancer	3.44e-07	3.37e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—EP300—hematologic cancer	3.36e-07	3.3e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—EP300—hematologic cancer	3.28e-07	3.22e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTEN—hematologic cancer	3.24e-07	3.18e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	3.21e-07	3.15e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTEN—hematologic cancer	3.21e-07	3.15e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.2e-07	3.14e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—EP300—hematologic cancer	3.09e-07	3.03e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—EP300—hematologic cancer	3.06e-07	3.01e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.97e-07	2.91e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.81e-07	2.76e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	2.78e-07	2.73e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ALB—hematologic cancer	2.78e-07	2.72e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.66e-07	2.61e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—AKT1—hematologic cancer	2.63e-07	2.58e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	2.48e-07	2.44e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.45e-07	2.41e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CA—hematologic cancer	2.43e-07	2.38e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.29e-07	2.24e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—AKT1—hematologic cancer	2.27e-07	2.23e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.27e-07	2.22e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTEN—hematologic cancer	2.12e-07	2.08e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—AKT1—hematologic cancer	2.03e-07	1.99e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—EP300—hematologic cancer	2.02e-07	1.98e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—AKT1—hematologic cancer	1.98e-07	1.94e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.87e-07	1.83e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—AKT1—hematologic cancer	1.85e-07	1.82e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.49e-07	1.47e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—AKT1—hematologic cancer	1.22e-07	1.2e-06	CbGpPWpGaD
